Refine by
Myeloma Suppliers & Manufacturers
47 companies found
based inPoway, CALIFORNIA (USA)
Diazyme uses its proprietary enzyme technologies to develop diagnostic reagents which can be used on most automated chemistry analyzers in user-friendly formats. Diazyme's products include test kits for diagnosis of cardiovascular disease, liver ...
based inSan Diego, CALIFORNIA (USA)
Aviva Systems Biology provides our customers with an extensive collection of quality antibodies for research and diagnostic applications. Aviva currently offers antibodies to more than 7,000 different protein targets due to our high throughput ...
Aviva provides customized solutions to each protein expression project. Our expert scientific staff has experience with difficult proteins and have produced more than 2,500 recombinant proteins. Whether your needs are small scale research or large ...
based inCarlton South, AUSTRALIA
Chimeric Therapeutics is a clinical stage cell therapy company focused on bringing the promise of cell therapy to life for more patients with cancer. We believe that cellular therapies have the promise to cure cancer not just delay disease ...
Cell therapy is the transfer of intact, live cells into a patient to help lessen or cure a disease. The most common and simple type of cell therapy is a blood transfusion. Other commonly known cell therapies include red and white blood cell ...
based inWehrheim, GERMANY
Heraeus Medical is a global leader specializing in bone cements and biomaterials for surgical orthopaedics and trauma surgery, notably supporting procedures like hip fracture repair, joint replacement, and spinal surgery. The company is renowned for ...
OSTEPAL Plus is a specialized low-viscosity bone cement designed for use in spinal surgeries, particularly in procedures such as vertebroplasty and kyphoplasty aimed at augmenting and stabilizing vertebral bodies. This product features a ...
based inCambridge, UNITED KINGDOM
Based in Cambridge, one of Europe's largest bioscience hubs, Biorbyt has a simple yet challenging mission: to provide the best service to the global scientific community. We achieve this by collaborating with the world’s finest researchers and ...
Plasma cells are specialised B lymphocytes that secrete antibodies (glycoproteins) in response to infection by antigens (toxins or foreign substances). Antibodies, also known as immunoglobulins (Ig), usually have a high affinity to a specific ...
based inMont-Saint-Guibert, BELGIUM
Celyad Oncology is a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer. We are developing a diversified pipeline of allogeneic and autologous CAR T cell ...
CYAD-211 is a short hairpin RNA (shRNA)-based allogeneic CAR T candidate for the treatment of relapsed or refractory multiple myeloma (r/r MM). CYAD-211 is engineered to co-express a B-cell maturation antigen (BCMA) chimeric antigen ...
based inHeidesee, GERMANY
As a leading developer and manufacturer in vitro diagnostics and reagents for enzyme immunoassays especially of ready-to-use substrates, Seramun Diagnostica GmbH is your partner when it comes to meet special requirements, ensuring highest-level ...
Polyclonal antibodies are raised in sheep and rabbits. Balb/c mice are used for monoclonal antibody production. Non- infectious, non-toxic antigens are provided by the customers. Special immunization schedules and methods induce high affinity ...
based inChangning District, CHINA
Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK) is a leading commercial-stage R&D-driven global biopharmaceutical company focused on the discovery, development, manufacturing and commercialization of innovative ...
Multiple myeloma is caused by the dysregulated proliferation of plasma cells, characterized by the proliferation of monoclonal plasma cells that results in an overabundance of monoclonal immunoglobulin or its fragment (M protein). ...
based inRadnor, PENNSYLVANIA (USA)
Avantor is a leading life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. We work side-by-side with customers at every step of the scientific journey to ...
based inVancouver, BRITISH COLUMBIA (CANADA)
STEMCELL Technologies provides high-quality cell culture media, cell separation technologies, instruments, accessory products, and educational resources to scientists around the world working on stem cell, immunology, cancer, regenerative medicine, ...
CryoStor® CS10 is recommended for the cryopreservation of hepatocytes, tissue samples, human peripheral blood, CHO cells, myeloma cell lines, hybridomas, human mesenchymal stem cells, human embryonic and human induced ...
based inAthens, GEORGIA (US) (USA)
Athens Research & Technology Inc. has been purifying human proteins and developing polyclonal antisera to those proteins since 1986. We specialize in highly pure, highly active human proteins. We routinely purify serine proteases, protease ...
In normal adult serum, the approximate percentage composition of IgA with respect to is subclasses is IgA1:90% and IgA2:10%. In secretory IgA, the subclass proportions may approach 50:50. The clinical significance of the subclasses has yet to be ...
based inBurnaby, BRITISH COLUMBIA (CANADA)
Artron Laboratories Inc. was founded in 2002 by a team of dedicated and talented research scientists. Today, Artron has established itself as a global leader in the progression of in vitro diagnostic lateral flow tests that have revolutionized the ...
Since its incorporation, Artron BioResearch Inc. has been using mouse hybridoma technology to produce monoclonal antibodies. Should you desire custom monoclonal antibodies to be developed against a provided antigen, our experienced and talented ...
based inHangzhou City, CHINA
Cnpair Biotech Co., Ltd. is a professional provider which concentrates on IVD core materials, including antibodies and proteins, and we are dedicated to developing and delivering highly competitive antibodies and proteins with outstanding ...
based inShirley, NEW YORK (USA)
Creative Bioarray is a leading customer-centered biotechnology company and a pioneer with the latest technology of cell patterning. Creative Bioarray has an experienced expert team and is committed to providing comprehensive services and customized ...
The SUP-T1 established from the pleural effusion of an 8-year-old boy with T-lymphoblastic lymphoma in relapse. These cells are E-rosette, Leu 5, OKT9 and CALLA negative. They also express β2M, Leu 1, 2, 3a, 4, 6, 9 and OKT10 antigens and are CD4 ...
based inFlorence, ITALY
The Menarini Group is a leading international pharmaceutical and diagnostics company, with a turnover of over $4 billion and over 17,000 employees. Menarini is focused on therapeutic areas with high unmet needs with products for cardiology, ...
NEXPOVIO is a first-in-class, oral exportin 1 (XPO1) inhibitor. XPO1 is a nuclear exporter protein that transport from the nucleus to the cytoplasm several proteins, including tumor suppressors, oncogenes, and proteins involved in governing cell ...
based inEatonton, GEORGIA (US) (USA)
Since 1979 Aalto Scientific has been a leader in the manufacture of OEM/Private label quality controls and calibrators, purified human proteins, and bulk human and animal sera to the in vitro diagnostic (IVD) manufacturing community. With over 40 ...
Cerebrospinal fluid (CSF) analysis is a set of laboratory tests that examine a sample of the fluid surrounding the brain and spinal cord. This fluid is a clear and colorless ultrafiltrate of plasma. It contains glucose, electrolytes, amino acids, ...
based inLake Forest, CALIFORNIA (USA)
Stanford Chemicals Company has over 16 years experience in the manufacturing and sales of phytochemicals, pharmaceutical intermediates, catalysts, lab equipment and a variety of special fine chemical products. We first provide analytic standards to ...
Hydroxychloroquine is usually taken with food or milk to prevent stomach upset. It was approved for medical use in the United States in 1955. It regulates the activity of the immune system and modifies the underlying disease process, rather than ...
based inGosselies, BELGIUM
SYnAbs was founded in 2015 as a Belgian spin-off of the Catholic University of Louvain (UCL), based on the work of Prof. Hervé Bazin, the inventor of the world's first rat myeloma cell line. SYnAbs' vision is to fill the gap on the marketplace for ...
That's why we've created SynAbs in the first place, based upon an exclusive asset: the rat-LOU species and rat-LOU IR983 myeloma cell line, developed in 1983 by Hervé Bazin in Catholique University of Louvain-la-Neuve (UCL). ...
based inUtrecht, NETHERLANDS
At LAVA, we are focused on applying our expertise in gamma-delta T cell engagers. We are building a pipeline of gamma-delta bsTCEs that have applications in both solid and hematologic malignancies. Our lead program, LAVA-051, targets the tumor ...
Our lead program, LAVA-051, is a unique, humanized gamma-delta bsTCE targeting CD1d-expressing tumors, including multiple myeloma, chronic lymphocytic leukemia (CLL), and acute myeloid leukemia (AML). We have achieved preclinical ...
based inMinneapolis, MINNESOTA (USA)
Cell Culture Company delivers whole cell pellets, cell lysates, custom monoclonal antibody and recombinant protein manufacturing services from development to commercialization. We employ traditional cell culture methods as well as automated, ...